Nexus Finance
8129.T TOHO HOLDINGS CO LTD | JP3602600003

Company Profile

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. The company sells pharmaceuticals, narcotics, reagents, and medical devices to hospitals, clinics, and dispensing pharmacies. It is also involved in the management of the dispensing pharmacies business; operates health insurance pharmacy; provision of support home medical care services; peripheral businesses; core system operations; and real estate agency business. In addition, the company manufacture and sell pharmaceuticals; sells generic drugs; and manufactures injection drugs on consignment. Further, it provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. Additionally, the company offers various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE Helios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin Nex-Sus, an inventory control system for large hospitals ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition. The company was incorporated in 1948 and is headquartered in Chuo, Japan.

Latest News

Sector Healthcare
Industry Medical Distribution
Website https://www.tohohd.co.jp
Audit Risk 1
Board Risk 2
Overall Risk 6
Market Cap 272.98B
Trailing P/E 16.18
Forward P/E 20.18
Dividend Rate 180
Dividend Yield 4.39%
Trailing Annual Div. Rate 165
Trailing Annual Div. Yield 4.02%
Trailing EPS 260.82
Forward EPS 209.1
Book Value 4,195.13
Price-to-Book 1.01
Enterprise-to-Revenue 0.12
Enterprise-to-EBITDA 7.95
Ex-Dividend Date 09/29/2026
Earnings Date 08/05/2026
Earnings Call Date
Revenue Average 387.72B
Revenue Low 387.72B
Revenue High 387.72B
ende